PhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 91 | Founded | a year ago | Last Issue | 6 days ago |
| Active | |||||
Read this Newsletter
spatialplex.substack.comLatest Issues
Geron Corporation (GERN)- A Profitable in Sight Telomerase Franchise With a Free Shot at a Myelofibrosis Survival Win.
Geron is a de-risked name in small cap heme-onc.
It already sells an approved, first in class drug and is engineered close to breakeven.
Its telomerase inhibitor, imetelstat (RYTELO), is approved in lower risk MDS and generating a fast g...
The Miss and the Math: What's Next for Connect Biopharma (CNTB)
Downgrade from bullish to NEUTRAL
We carried a bullish view on Connect Biopharma:
The Catalyst Hit: Does the 'Avoid' Call on Ultragenyx Still Hold?
Last month, i wrote about three biotech plays to AVOID.
Last month, i wrote about three biotech plays to AVOID. One of them was Ultragenyx (RARE).
Connect Biopharma (CNTB )--Rademikibart's Acute-Asthma Study Missed Its Primary Endpoint
The CNTB readout landed, yesterday.
The market hated it and the share tumbled.
Phase 2 Seabreeze STAT study of rademikibart (an anti-IL-4Rα antibody) as an add on for acute asthma exacerbations showed a ~66% reduction in Day 28 treatment...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for JojoFinanceNotes.
| Subscribers | Engagement | 76 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #243 |
Authors
The writers behind this newsletter.
PhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
Frequently Asked Questions
How can I access the email archive for JojoFinanceNotes?
You can find recent issues that have been published by JojoFinanceNotes on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does JojoFinanceNotes have?
To see how many people subscribe to JojoFinanceNotes, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in JojoFinanceNotes?
Newsletter advertising can be extremely effective when it's done right. Before you pitch JojoFinanceNotes as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like JojoFinanceNotes?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact JojoFinanceNotes using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to JojoFinanceNotes?
Scroll up to where it says Related Newsletters to see other publications like JojoFinanceNotes. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact JojoFinanceNotes?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.